SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    D.G. Yaşar, E. Suyanı, S. Özenirler, G.T. Sucak, Adefovir Is Effective to Promote Development of Immunity to Donor Origin Hepatitis B Virus in an Allogeneic Transplant Recipient: A Case Report, Transplantation Proceedings, 2013, 45, 2, 833

    CrossRef

  2. 2
    Edward J. Gane, Scott Patterson, Simone I. Strasser, Geoffrey W. McCaughan, Peter W. Angus, Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen–positive liver transplant candidates, Liver Transplantation, 2013, 19, 3
  3. 3
    A. Perrakis, T. Förtsch, A. Del Medico, R.S. Croner, N. Vassos, S. Yedibela, C. Lohmüller, S. Zopf, W. Hohenberger, V. Müller, Liver Transplantation for Hepatitis B-Induced Liver Disease: Long-Term Outcome and Effectiveness of Antiviral Therapy for Prevention of Recurrent Hepatitis B Infection, Transplantation Proceedings, 2013, 45, 5, 1953

    CrossRef

  4. 4
    James Fung, See-Ching Chan, Cindy Cheung, Man-Fung Yuen, Kenneth Siu-Ho Chok, William Sharr, Albert Chi-Yan Chan, Tan-To Cheung, Wai-Kay Seto, Sheung-Tat Fan, Ching-Lung Lai, Chung-Mau Lo, Oral Nucleoside/Nucleotide Analogs Without Hepatitis B Immune Globulin After Liver Transplantation for Hepatitis B, The American Journal of Gastroenterology, 2013, 108, 6, 942

    CrossRef

  5. 5
    Tiffany CL Wong, James YY Fung, Chung Mau Lo, Prevention of recurrent hepatitis B infection after liver transplantation, Hepatobiliary & Pancreatic Diseases International, 2013, 12, 5, 465

    CrossRef

  6. 6
    Bruno Roche, Didier Samuel, Treatment of Patients with HBV-related Decompensated Cirrhosis and Liver Transplanted Patients, Clinics in Liver Disease, 2013, 17, 3, 451

    CrossRef

  7. 7
    J. Levitsky, K. Doucette, Viral Hepatitis in Solid Organ Transplantation, American Journal of Transplantation, 2013, 13, s4
  8. 8
    Maria C Segovia, Wadih Chacra, Stuart C Gordon, Adefovir dipivoxil in chronic hepatitis B: history and current uses, Expert Opinion on Pharmacotherapy, 2012, 13, 2, 245

    CrossRef

  9. 9
    E. Cholongitas, T. Vasiliadis, N. Antoniadis, I. Goulis, V. Papanikolaou, E. Akriviadis, Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation, Transplant Infectious Disease, 2012, 14, 5
  10. 10
    Corinne Buchanan, Tram T. Tran, Current Status of Liver Transplantation for Hepatitis B Virus, Clinics in Liver Disease, 2011, 15, 4, 753

    CrossRef

  11. 11
    Zuoyi Jiao, Youcheng Zhang, Lin Han, Yong Zeng, Lunan Yan, Four-year follow-up of two chronic hepatitis B recipients of hepatitis B surface antigen-positive cadaveric liver grafts from asymptomatic carriers, Hepatology Research, 2011, 41, 9
  12. 12
    Evangelos Cholongitas, John Goulis, Evangelos Akriviadis, Geore V. Papatheodoridis, Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic review, Liver Transplantation, 2011, 17, 10
  13. 13
    S. Saab, S. Desai, D. Tsaoi, F. Durazo, S. Han, A. McClune, C. Holt, D. Farmer, L. Goldstein, R. W. Busuttil, Posttransplantation Hepatitis B Prophylaxis with Combination Oral Nucleoside and Nucleotide Analog Therapy, American Journal of Transplantation, 2011, 11, 3
  14. 14
    Shin Hwang, Chul-Soo Ahn, Gi-Won Song, Ki-Hun Kim, Deok-Bog Moon, Heung-Bum Oh, Young-Suk Lim, Han Chu Lee, Tae-Yong Ha, Dong-Hwan Jung, Young-Hwa Chung, Sung-Gyu Lee, Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on, Liver Transplantation, 2011, 17, 4
  15. 15
    T. Karlas, J. Hartmann, A. Weimann, M. Maier , M. Bartels, S. Jonas, J. Mössner, T. Berg, H.L. Tillmann, J. Wiegand, Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only, Transplant Infectious Disease, 2011, 13, 3
  16. 16
    Ed Gane, Hepatitis B immunoglobulin immunoprophylaxis for hepatitis B: High, low, or no dose?, Liver Transplantation, 2010, 16, S2
  17. 17
    B. Degertekin, Steven-Huy B. Han, E. B. Keeffe, E. R. Schiff, V. A. Luketic, R. S. Brown, Jr., S. Emre, C. Soldevila-Pico, K. R. Reddy, M. B. Ishitani, T. T. Tran, T. L. Pruett, A. S. F. Lok, Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation, American Journal of Transplantation, 2010, 10, 8
  18. 18
    Kai Chung Tse, Desmond Y. H. Yap, Colin S. O. Tang, Susan Yung, Tak Mao Chan, Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B, Clinical Transplantation, 2010, 24, 2
  19. 19
    Sammy Saab, Maggie Y. Ham, Michael A. Stone, Curtis Holt, Myron Tong, Decision analysis model for hepatitis B prophylaxis one year after liver transplantation, Liver Transplantation, 2009, 15, 4
  20. 20
    Susanne Beckebaum, Georgios C. Sotiropoulos, Guido Gerken, Vito R. Cicinnati, Hepatitis B and liver transplantation: 2008 update, Reviews in Medical Virology, 2009, 19, 1
  21. 21
    Anne Marie Roque-Afonso, Hepatitis B virus cellular immunity after liver transplantation: A role in preventing hepatitis B virus recurrence?, Liver Transplantation, 2009, 15, 3
  22. 22
    M. Bahra, D. Seehofer, U.P. Neumann, T. Berg, Hepatitis-B- und -C-Reinfektion: Prophylaxe und Therapie, Der Gastroenterologe, 2009, 4, 6, 526

    CrossRef

  23. 23
    Jenny L. Limquiaco, John Wong, Vincent W.S. Wong, Grace L.H. Wong, Chi-Hang Tse, Hoi-Yun Chan, Katherine Y.Y. Kwan, Paul B.S. Lai, Henry L.Y. Chan, Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: A seven-year follow-up study, Journal of Medical Virology, 2009, 81, 2
  24. 24
    Scott J Patterson, Peter W Angus, Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues, Current Opinion in Organ Transplantation, 2009, 14, 3, 225

    CrossRef

  25. 25
    D. Samuel, The option of liver transplantation for hepatitis B: Where are we?, Digestive and Liver Disease, 2009, 41, S185

    CrossRef

  26. 26
    J. Levitsky, K. Doucette, Viral Hepatitis in Solid Organ Transplant Recipients, American Journal of Transplantation, 2009, 9,
  27. 27
    Hussien Elsiesy, Douglas Dieterich, Dual therapy for chronic hepatitis B virus, Current Hepatitis Reports, 2008, 7, 1, 33

    CrossRef

  28. 28
    Bruno Roche, Didier Samuel, Liver transplantation in viral hepatitis: Prevention of recurrence, Best Practice & Research Clinical Gastroenterology, 2008, 22, 6, 1153

    CrossRef

  29. 29
    Shin Hwang, Sung-Gyu Lee, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Jung-Ik Park, Je-Ho Ryu, Hyo-Jun Lee, Dong-Jin Suh, Young-Suk Lim, Prevention of hepatitis B recurrence after living donor liver transplantation: Primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy, Liver Transplantation, 2008, 14, 6
  30. 30
    D. Samuel, Transplantation hépatique pour hépatite chronique B, Gastroentérologie Clinique et Biologique, 2008, 32, 1, S25

    CrossRef

  31. 31
    Bijal Surti, Amanda C. Chi, Sammy Saab, Update on management of hepatitis B before and after liver transplantation, Current Hepatitis Reports, 2008, 7, 1, 25

    CrossRef

  32. 32
    Dennis A. Freshwater, Tracey Dudley, Patricia Cane, David J. Mutimer, Viral Persistence After Liver Transplantation for Hepatitis B Virus: A Cross-Sectional Study, Transplantation, 2008, 85, 8, 1105

    CrossRef

  33. 33
    Eugene Schiff, Ching-Lung Lai, Stephanos Hadziyannis, Peter Neuhaus, Norah Terrault, Massimo Colombo, Hans Tillmann, Didier Samuel, Stefan Zeuzem, Jean-Pierre Villeneuve, Sarah Arterburn, Katyna Borroto-Esoda, Carol Brosgart, Steven Chuck, Adefovir dipivoxil for wait-listed and post–liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results, Liver Transplantation, 2007, 13, 3
  34. 34
    Murat Akyildiz, Zeki Karasu, Murat Zeytunlu, Unal Aydin, Tijen Ozacar, Murat Kilic, Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis, Journal of Gastroenterology and Hepatology, 2007, 22, 12
  35. 35
    Maria Buti, Antoni Mas, Martin Prieto, Fernando Casafont, Antonio González, Manuel Miras, Jose Ignacio Herrero, Rosendo Jardi, Rafael Esteban, Adherence to Lamivudine After an Early Withdrawal of Hepatitis B Immune Globulin Plays an Important Role in the Long-Term Prevention of Hepatitis B Virus Recurrence, Transplantation, 2007, 84, 5, 650

    CrossRef

  36. 36
    Jens Rosenau, Therese Kreutz, Matthias Kujawa, Matthias J. Bahr, Kinan Rifai, Nazanin Hooman, Andrea Finger, Gerd Michel, Björn Nashan, Ernst R. Kuse, Jürgen Klempnauer, Hans L. Tillmann, Michael P. Manns, HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration, Journal of Hepatology, 2007, 46, 4, 635

    CrossRef

  37. 37
    Nobuyuki Takemura, Yasuhiko Sugawara, Sumihito Tamura, Masatoshi Makuuchi, Liver Transplantation Using Hepatitis B Core Antibody−Positive Grafts: Review and University of Tokyo Experience, Digestive Diseases and Sciences, 2007, 52, 10, 2472

    CrossRef

  38. 38
    Melissa K. Osborn, Steven H. Han, Arie Regev, Natalie H. Bzowej, Michael B. Ishitani, Tram T. Tran, Anna S.F. Lok, Outcomes of Patients With Hepatitis B Who Developed Antiviral Resistance While on the Liver Transplant Waiting List, Clinical Gastroenterology and Hepatology, 2007, 5, 12, 1454

    CrossRef

  39. 39
    J. Prada Lobato, S. Garrido López, M.A. Catalá Pindado, F. García Pajares, Profilaxis de reinfección por el virus de la hepatitis B postrasplante hepático, Farmacia Hospitalaria, 2007, 31, 1, 30

    CrossRef

  40. 40
    Michael P. Curry, Nezam H. Afdhal, Prophylaxis against recurrent hepatitis B virus infection after liver transplantation, Current Hepatitis Reports, 2007, 6, 1, 30

    CrossRef

  41. 41
    Marco Antonio Olivera-Martínez, Juan F. Gallegos-Orozco, Recurrent Viral Liver Disease (Hepatitis B and C) after Liver Transplantation, Archives of Medical Research, 2007, 38, 6, 691

    CrossRef

  42. 42
    R. Bárcena Marugán, Adefovir en el tratamiento de la infección por virus B, Gastroenterología y Hepatología, 2006, 29, 36

    CrossRef

  43. 43
    Shin Hwang, Sung-Gyu Lee, Kwang-Min Park, Ki-Hun Kim, Chul-Soo Ahn, Heung-Bum Oh, Deok-Bog Moon, Tae-Yong Ha, Young-Suk Lim, Dong-Hwan Jung, Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft, Liver Transplantation, 2006, 12, 6
  44. 44
    Robert G. Gish, Timothy McCashland, Hepatitis B in liver transplant recipients, Liver Transplantation, 2006, 12, S2
  45. 45
    Christoph Eisenbach, Peter Sauer, Arianeb Mehrabi, Wolfgang Stremmel, Jens Encke, Prevention of hepatitis B virus recurrence after liver transplantation, Clinical Transplantation, 2006, 20,
  46. 46
    D. MUTIMER, Review article: hepatitis B and liver transplantation, Alimentary Pharmacology & Therapeutics, 2006, 23, 8
  47. 47
    Ed Gane, Liver Transplantation for Chronic Hepatitis B and C,
  48. 48
    Evangelos Cholongitas, George V Papatheodoridis, Management of HBV Infection and Liver Transplantation,
  49. 49
    Ed Gane, Prevention and Treatment of Recurrent HBV and HCV Infection,
  50. 50
    Kymberly D. S. Watt, Marie A. Laryea, Recurrent Disease Following Liver Transplantation,